| Name | Title | Contact Details |
|---|
Portola Pharmaceuticals is dedicated to developing and commercializing therapies that transform patient lives and advance patient care by changing treatment paradigms in thrombosis and other hematologic diseases. Our two lead assets are Bevyxxa® (betrixaban), and andexanet alfa. In addition, cerdulatinib is our investigational Syk/JAK inhibitor to treat hematologic cancers. These compounds come from our own internal research efforts and represent important advances to address significant unmet needs. We are employing novel strategies that may increase the likelihood of clinical, regulatory and commercial success of our potentially lifesaving therapies.
QualChoice, our commitment is to your good health. Our vision is to become the health plan in this region that is most preferred by households, businesses, and the medical community.
Prexus Health is one of the leading companies in the Healthcare, Pharmaceuticals, and Biotech sector.
A Great Day Starts With A Good Night!
Health Products Express is a Winthrop, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.